BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33432417)

  • 1. Plasminogen activator inhibitor-1 reduces cardiac fibrosis and promotes M2 macrophage polarization in inflammatory cardiomyopathy.
    Baumeier C; Escher F; Aleshcheva G; Pietsch H; Schultheiss HP
    Basic Res Cardiol; 2021 Jan; 116(1):1. PubMed ID: 33432417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac macrophages adopt profibrotic/M2 phenotype in infarcted hearts: Role of urokinase plasminogen activator.
    Carlson S; Helterline D; Asbe L; Dupras S; Minami E; Farris S; Stempien-Otero A
    J Mol Cell Cardiol; 2017 Jul; 108():42-49. PubMed ID: 27262672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural cell adhesion molecule expression in dilated cardiomyopathy is associated with intramyocardial inflammation and hypertrophy.
    Ostermann K; Schultheiss HP; Noutsias M
    Int J Cardiol; 2017 Aug; 241():322-325. PubMed ID: 28343767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy.
    Wu L; Ong S; Talor MV; Barin JG; Baldeviano GC; Kass DA; Bedja D; Zhang H; Sheikh A; Margolick JB; Iwakura Y; Rose NR; Ciháková D
    J Exp Med; 2014 Jun; 211(7):1449-64. PubMed ID: 24935258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic value of small molecule inhibitor to plasminogen activator inhibitor-1 for lung fibrosis.
    Huang WT; Vayalil PK; Miyata T; Hagood J; Liu RM
    Am J Respir Cell Mol Biol; 2012 Jan; 46(1):87-95. PubMed ID: 21852684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of the presence of macrophages in endomyocardial biopsies of patients with dilated cardiomyopathy.
    Nakayama T; Sugano Y; Yokokawa T; Nagai T; Matsuyama TA; Ohta-Ogo K; Ikeda Y; Ishibashi-Ueda H; Nakatani T; Ohte N; Yasuda S; Anzai T
    Eur J Heart Fail; 2017 Apr; 19(4):490-498. PubMed ID: 28217949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
    Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
    Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation.
    Gupta KK; Donahue DL; Sandoval-Cooper MJ; Castellino FJ; Ploplis VA
    Sci Rep; 2017 Mar; 7(1):365. PubMed ID: 28336948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy.
    Chen P; Xie Y; Shen E; Li GG; Yu Y; Zhang CB; Yang Y; Zou Y; Ge J; Chen R; Chen H
    Eur J Pharmacol; 2011 May; 658(2-3):168-74. PubMed ID: 21371462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-β-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts.
    Omori K; Hattori N; Senoo T; Takayama Y; Masuda T; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Kohno N
    PLoS One; 2016; 11(2):e0148969. PubMed ID: 26859294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen Activator Inhibitor-1 Promotes the Recruitment and Polarization of Macrophages in Cancer.
    Kubala MH; Punj V; Placencio-Hickok VR; Fang H; Fernandez GE; Sposto R; DeClerck YA
    Cell Rep; 2018 Nov; 25(8):2177-2191.e7. PubMed ID: 30463014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β/Smad3 signalling regulates the transition of bone marrow-derived macrophages into myofibroblasts during tissue fibrosis.
    Wang S; Meng XM; Ng YY; Ma FY; Zhou S; Zhang Y; Yang C; Huang XR; Xiao J; Wang YY; Ka SM; Tang YJ; Chung AC; To KF; Nikolic-Paterson DJ; Lan HY
    Oncotarget; 2016 Feb; 7(8):8809-22. PubMed ID: 26684242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of functional T-cell markers and T-cell receptor Vbeta repertoire in endomyocardial biopsies from patients presenting with acute myocarditis and dilated cardiomyopathy.
    Noutsias M; Rohde M; Göldner K; Block A; Blunert K; Hemaidan L; Hummel M; Blohm JH; Lassner D; Kühl U; Schultheiss HP; Volk HD; Kotsch K
    Eur J Heart Fail; 2011 Jun; 13(6):611-8. PubMed ID: 21422001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M1- and M2-macrophage polarization in rat liver cirrhosis induced by thioacetamide (TAA), focusing on Iba1 and galectin-3.
    Wijesundera KK; Izawa T; Tennakoon AH; Murakami H; Golbar HM; Katou-Ichikawa C; Tanaka M; Kuwamura M; Yamate J
    Exp Mol Pathol; 2014 Jun; 96(3):382-92. PubMed ID: 24747241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
    Lian R; Chen Y; Xu Z; Zhang X
    Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy.
    Besler C; Urban D; Watzka S; Lang D; Rommel KP; Kandolf R; Klingel K; Thiele H; Linke A; Schuler G; Adams V; Lurz P
    Eur J Heart Fail; 2016 Dec; 18(12):1442-1451. PubMed ID: 27292200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAI-1 mediates TGF-β1-induced myofibroblast activation in tenocytes via mTOR signaling.
    Alenchery RG; Ajalik RE; Jerreld K; Midekksa F; Zhong S; Alkatib B; Awad HA
    J Orthop Res; 2023 Oct; 41(10):2163-2174. PubMed ID: 37143206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis.
    Flevaris P; Khan SS; Eren M; Schuldt AJT; Shah SJ; Lee DC; Gupta S; Shapiro AD; Burridge PW; Ghosh AK; Vaughan DE
    Circulation; 2017 Aug; 136(7):664-679. PubMed ID: 28588076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.